UroGen Pharma Ltd. (NASDAQ:URGN) Q2 2025 Earnings Call Transcript August 9, 2025
Operator: Good day, and thank you for standing by. Welcome to the UroGen Pharma Second Quarter 2025 Earnings Call. [Operator Instructions] Please be advised that today’s conference is being recorded. I’d now like to go ahead and hand the conference over to your first speaker today, Vincent Perrone, Investor Relations. Vincent, you have the floor.
Vincent I. Perrone: Thank you, operator. Good morning, everyone,...
